On Monday, Unity Biotechnology Inc (NASDAQ: UBX) was -28.77% drop from the session before settling in for the closing price of $1.83. A 52-week range for UBX has been $0.94 – $3.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -39.01% over the past five years. When this article was written, the company’s average yearly earnings per share was at 27.87%. With a float of $15.38 million, this company’s outstanding shares have now reached $16.87 million.
Let’s look at the performance matrix of the company that is accounted for 16 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Unity Biotechnology Inc (UBX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Unity Biotechnology Inc stocks. The insider ownership of Unity Biotechnology Inc is 8.79%, while institutional ownership is 12.53%. The most recent insider transaction that took place on Feb 04 ’25, was worth 341. In this transaction CFO & Head of Corp. Dev. of this company sold 153 shares at a rate of $2.23, taking the stock ownership to the 55,772 shares. Before that another transaction happened on Feb 04 ’25, when Company’s CLO and Head of Ops sold 164 for $2.23, making the entire transaction worth $366. This insider now owns 24,559 shares in total.
Unity Biotechnology Inc (UBX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.80% during the next five years compared to 39.36% growth over the previous five years of trading.
Unity Biotechnology Inc (NASDAQ: UBX) Trading Performance Indicators
You can see what Unity Biotechnology Inc (UBX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.86 in one year’s time.
Technical Analysis of Unity Biotechnology Inc (UBX)
Unity Biotechnology Inc (NASDAQ: UBX) saw its 5-day average volume 0.44 million, a positive change from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 39.02%. Additionally, its Average True Range was 0.22.
During the past 100 days, Unity Biotechnology Inc’s (UBX) raw stochastic average was set at 16.68%, which indicates a significant decrease from 17.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.19% in the past 14 days, which was higher than the 130.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9036, while its 200-day Moving Average is $1.5044. Nevertheless, the first resistance level for the watch stands at $1.4067 in the near term. At $1.5133, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6367. If the price goes on to break the first support level at $1.1767, it is likely to go to the next support level at $1.0533. The third support level lies at $0.9467 if the price breaches the second support level.
Unity Biotechnology Inc (NASDAQ: UBX) Key Stats
There are 16,868K outstanding shares of the company, which has a market capitalization of 21.93 million. As of now, sales total 0 K while income totals -25,990 K. Its latest quarter income was 0 K while its last quarter net income were -8,440 K.
